More than 500 cases have been reported this year through March 16, according to the Centers for Disease Control and Prevention. Transmission rates in the US are still lower than those reported in 2022. However, experts say that vaccination rates in the US are still low, leaving many at risk.
The George Washington University has experts available to comment on mpox cases vaccination rates and transmission patterns. To schedule an interview please contact KathyFacklemann at kfackelmann
gwu [dot] edu.
David Diemert, clinical director of the GW Vaccine Research Unit and professor of medicine at the GW School of Medicine & Health Sciences, can talk about the risk of mpox spreading in the US. Diemert and his colleagues are evaluating the immune response and safety of the JYNNEOS vaccine for mpox in adolescents.
Christopher Mores, professor of global health at the GW Milken Institute School of Public Health, is a virologist and can discuss the spread, risk and modes of transmission of mpox. He is the director of a high-containment research laboratory and has investigated outbreaks of Ebola, Zika and others. Mores works closely with the US government and industry on measures to contain or stop emerging disease threats.
-GW-